Dr. Paul Waytz

And so that's why if you go to a cardiologist, they may want to do a test called a CRP, which is a marker of inflammation, which might identify at risk people because so it's a secondary effect. Now, again, we're doing a better job, but it's still you got to you got to take care of all these things. And as rheumatologists, we learn to become almost like primary care docs for our patients.

And so that's why if you go to a cardiologist, they may want to do a test called a CRP, which is a marker of inflammation, which might identify at risk people because so it's a secondary effect. Now, again, we're doing a better job, but it's still you got to you got to take care of all these things. And as rheumatologists, we learn to become almost like primary care docs for our patients.

Yeah. And going back to Clarence's original question about women with lupus, black women with lupus have the highest incidence of mortality. So now, So, you know, we live in Minnesota, which is a pretty white place.

Yeah. And going back to Clarence's original question about women with lupus, black women with lupus have the highest incidence of mortality. So now, So, you know, we live in Minnesota, which is a pretty white place.

And so we may be a little we're not maybe not recognizing it. Now, things are changing. Obviously, I trained in Chicago. I did med school in Chicago and a Cook County hospital where it was different. I think there's a number of components here.

And so we may be a little we're not maybe not recognizing it. Now, things are changing. Obviously, I trained in Chicago. I did med school in Chicago and a Cook County hospital where it was different. I think there's a number of components here.

One of which goes back, and again, we're getting into a little DEI stuff, is that people of color and people of various underrepresented groups will do better when they see a physician who looks like themselves. And that's been known. So if I was a black man and I had a white doc,

One of which goes back, and again, we're getting into a little DEI stuff, is that people of color and people of various underrepresented groups will do better when they see a physician who looks like themselves. And that's been known. So if I was a black man and I had a white doc,

whether I'm perceived to be complaining or not complaining, there'd be a tendency to not maybe go to him for the aches and pains and to say, I'm just going to put up with my aches and pains. You know, I'm just using that as an example. Yeah.

whether I'm perceived to be complaining or not complaining, there'd be a tendency to not maybe go to him for the aches and pains and to say, I'm just going to put up with my aches and pains. You know, I'm just using that as an example. Yeah.

Yeah. And you can have better outcomes when you see a doc that looks like you.

Yeah. And you can have better outcomes when you see a doc that looks like you.

That's been proven over and over again. So is it an incidence issue or is it just, um, is it just, um, you know, um, you know, I hate to say bias issue or, or, uh, that kind of thing. Um, so it's, it's very interesting. Um, I just want to get back to those statistics. When you say all these people go to the doctor or whatever, there's a lot of people who are not going to the doctor, too. Correct.

That's been proven over and over again. So is it an incidence issue or is it just, um, is it just, um, you know, um, you know, I hate to say bias issue or, or, uh, that kind of thing. Um, so it's, it's very interesting. Um, I just want to get back to those statistics. When you say all these people go to the doctor or whatever, there's a lot of people who are not going to the doctor, too. Correct.

They haven't. These are just the ones that do. Yeah, so you do a study at one point in time, and that's going to change. The overall statistics for rheumatoid arthritis involves 1% to 2% of the population. And you say, well, 1% to 2% isn't a lot. Hey, 1% to 2% is a lot. Of that 1% to 2%, about 5% are kids under the age of 16. So there's a condition called juvenile.

They haven't. These are just the ones that do. Yeah, so you do a study at one point in time, and that's going to change. The overall statistics for rheumatoid arthritis involves 1% to 2% of the population. And you say, well, 1% to 2% isn't a lot. Hey, 1% to 2% is a lot. Of that 1% to 2%, about 5% are kids under the age of 16. So there's a condition called juvenile.

We used to call it juvenile rheumatoid arthritis. Now it's called juvenile inflammatory arthritis. Um, so I can't even remember what the original point was, Stan, but there's a lot of arthritis going on and, and people in underrepresented groups don't, don't necessarily do as well.

We used to call it juvenile rheumatoid arthritis. Now it's called juvenile inflammatory arthritis. Um, so I can't even remember what the original point was, Stan, but there's a lot of arthritis going on and, and people in underrepresented groups don't, don't necessarily do as well.

And whether that's genetics, um, or it's because they're not getting to the care that they should be at the right time. It's, it's a complex issue that, you know, it's on my mind. I know it should be.

And whether that's genetics, um, or it's because they're not getting to the care that they should be at the right time. It's, it's a complex issue that, you know, it's on my mind. I know it should be.